Trial intelligence / Profile preview

Analgesic Effect of Intranasal Calcitonin on Patients With Fractured Ribs

NCT00444808Phase 4Terminated

Sponsor
Université de Montréal
Start
Feb 2007
Modality
Peptides, Small Molecules
Countries
1
01

Overview

A Phase 4 trial of TBRIA in rib fracture, pain, sponsored by Université de Montréal. Started Feb 2007; status: terminated.

02

Drugs

TBRIA
03

Conditions

rib fracturepain

Beyond the preview

Go deeper on NCT00444808.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00444808.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call